Add time:07/23/2019         Source:sciencedirect.com

From June 1987 to June 1995, 200 patients with various types of head and neck lymphangioma were treated by intratumorous injection of bleomycin-A5. All 200 cases were followed from 2 to 10 years; 95 cases were followed for more than 5 years. The effective rate was 97%, and the curative rate was 86.5%. No pulmofibrosis or other serious complications were found. The relationships between the curative effect and tumor type, size, and side effects of bleomycin are discussed.

We also recommend Trading Suppliers and Manufacturers of Bleomycin A5 (cas 11116-32-8). Pls Click Website Link as below: cas 11116-32-8 suppliers